A Multicenter, Randomized, Double-blind, and Parallel Groups, Placebo-controlled Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain.
The purpose of this study is to study the efficacy of intravenous administration of ibuprofen compared to placebo in patients with postoperative pain and evaluate its tolerability and safety profile.
100 Clinical Results associated with Biomendi SAU
0 Patents (Medical) associated with Biomendi SAU
100 Deals associated with Biomendi SAU
100 Translational Medicine associated with Biomendi SAU